Back
Vanguard Dividend Appreciation ETF Vs. Neurocrine Biosciences Industry Stock Comparison
Buy
74
VIG
Vanguard Dividend Appreciation ETF
Last Price:
196.29
Seasonality Move:
3.12%
Sell
43
NBIX
Neurocrine Biosciences
Last Price:
122.37
Seasonality Move:
9.9%
Buy
74
Vanguard Dividend Appreciation ETF (VIG)
is a Buy
Is Vanguard Dividend Appreciation ETF a Buy, Sell or Hold?
- The current Vanguard Dividend Appreciation ETF [VIG] share price is $196.42. The Score for VIG is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- VIG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $122.31. The Score for NBIX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NBIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VIG Stock Price Chart
What is Vanguard Dividend Appreciation ETF's stock price today?
-
The Vanguard Dividend Appreciation ETF share price today is $196.42
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VIG is experiencing slight selling pressure.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $122.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight buying pressure.
VIG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.74 | Buy |
Relative Strength Index (14 RSI): | 63.99 | Buy |
Chaikin Money Flow: | -123693 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NBIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.35 | Sell |
Relative Strength Index (14 RSI): | 33.57 | Sell |
Chaikin Money Flow: | 30053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.92 - 148.42) | Sell |
Bollinger Bands (100): | (130.53 - 147.55) | Sell |
VIG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 194.1 | Buy |
20-day SMA: | 193.73 | Buy |
50-day SMA: | 189.82 | Buy |
200-day SMA: | 179.97 | Buy |
8-day EMA: | 194.92 | Buy |
20-day EMA: | 193.3 | Buy |
50-day EMA: | 190.19 | Buy |
200-day EMA: | 180.36 | Buy |
NBIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 121.19 | Buy |
20-day SMA: | 131.41 | Sell |
50-day SMA: | 140.45 | Sell |
200-day SMA: | 136.3 | Sell |
8-day EMA: | 122.77 | Sell |
20-day EMA: | 128.78 | Sell |
50-day EMA: | 135.6 | Sell |
200-day EMA: | 133.33 | Sell |
Vanguard Dividend Appreciation ETF Earnings Growth & VIG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.
Vanguard Dividend Appreciation ETF Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurocrine Biosciences Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |